cancer research
ICR: ‘Pharma needs stronger incentives’
February 12, 2014Research and Development, Sales and Marketing ICR, cancer research, itcc, pharma, r and d
The pharma industry must be given greater monetary help to persuade it to develop drugs which are specifically for children, …
Funding boost for lung cancer ‘map’
July 18, 2013Research and Development, Sales and Marketing cancer research, lung cancer, tracerx
A new Cancer Research UK study aims to unlock lung cancer’s secrets by tracking how lung tumours develop and evolve …
Melanoma: intense competition to be the next milestone treatment
February 9, 2011Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab
A flurry of new data has emerged in the recent months from an industry-wide pipeline of cancer drugs which could …
Sanofi buys into cancer antibody research
January 26, 2011Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research
Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …
Sanofi signs new oncology research deals
December 20, 2010Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs
Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
Novartis drops late stage lung cancer candidate
November 11, 2010Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer
Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
